A fibroblast-derived human growth factor preparation for the management of acute radiodermatitis: A case report

3Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Radiotherapy is a commonly used modality in breast cancer management. Amongst the consequences of treatment are acute and/or chronic skin changes, which often lead to itching, pain, and a diminished aesthetic appearance, all of which greatly impact the patient’s quality of life. Management of radiation-induced skin effects has not as yet been standardized, with various protocols being applied by different radiotherapy departments. This case study outlines the management of a grade 3 acute radiodermatitis in a female with a synergistic preparation of anti-inflammatory cytokines and growth factors derived from human fibroblasts. The treatment resulted in the total resolution of the radia-tion-induced skin reaction, with a minimally visible residual scar.

Cite

CITATION STYLE

APA

Vadarli, G., & Angelo-Khattar, M. (2020). A fibroblast-derived human growth factor preparation for the management of acute radiodermatitis: A case report. International Medical Case Reports Journal, 13, 691–696. https://doi.org/10.2147/IMCRJ.S287033

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free